All AbMole products are for research use only, cannot be used for human consumption.
ST2825 significantly inhibited the proliferation of and promoted the apoptosis of HCC cells. Moreover, ST2825 significantly decreased bcl-2 expression, increased cleaved caspase-3 expression (P < 0.05), and reduced p65 nuclear expression (P < 0.05) in a dose-dependent manner.
In vivo, animals are administered orally with the appropriate vehicles or ST2825 at doses ranging from 50 to 200 mg/kg, 5 min prior to i.p. injection with 20 μg/kg IL-1β. ST2825 exertes a significant inhibition of IL-1β-stimulated production of IL-6 at 100 and 200 mg/kg.
Int J Biol Macromol. 2025 Jun 20; .
Immunoregulatory function and anticancer effects of Polygonatum sibiricum polysaccharides against hepatic carcinoma via macrophage phenotype modulation
ST2825 purchased from AbMole
| Molecular Weight | 591.51 |
| Formula | C27H28Cl2N4O5S |
| CAS Number | 894787-30-5 |
| Form | Solid |
| Solubility (25°C) | DMSO 10 mM |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Immunology/Inflammation Products |
|---|
| Aloe Polysaccharide
Aloe Polysaccharides are the primary bioactive components of aloe vera gel, primarily found in the gel-like portion of the aloe vera leaf, specifically the transparent, viscous section enclosed by the leaf epidermis. Aloe polysaccharides are a large class of macromolecular compounds with diverse physiological functions, primarily composed of mannose, galactose, glucose, xylose, arabinose, and rhamnose, with mannose, galactose, and glucose being the most abundant. They exhibit various bioactivities, including antibacterial and anti-inflammatory effects, antiviral activity, immune modulation, antitumour properties, radiation protection, antioxidant properties, and hypoglycaemic effects. |
| Terminalia Chebula Extract
Terminalia Chebula Extract is extracted from Terminalia Chebula, which has antioxidant, hepatoprotective, neuroprotective, cytotoxic, antidiabetic, and anti-inflammatory activities. |
| SMS121
SMS121 is a novel CD36 inhibitor. SMS121 reduced the uptake of fatty acid into AML cells that could be reversed by addition of free fatty acids and caused decreased cell viability. |
| Rolistobart
Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. |
| Gemtuzumab
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for the synthesis of antibody-drug conjugate (ADC) Gemtuzumab ozogamicin. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
